Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 2.25%
March 31, 2026 2.74%
December 31, 2025 3.15%
September 30, 2025 -43.84%
June 30, 2025 3.84%
March 31, 2025 4.08%
December 31, 2024 29.67%
September 30, 2024 3.37%
June 30, 2024 5.46%
March 31, 2024 3.60%
December 31, 2023 5.72%
September 30, 2023 6.30%
June 30, 2023 -0.42%
March 31, 2023 6.82%
December 31, 2022 7.89%
September 30, 2022 9.00%
June 30, 2022 9.81%
March 31, 2022 9.76%
Date Value
December 31, 2021 4.93%
September 30, 2021 8.55%
June 30, 2021 8.49%
March 31, 2021 9.18%
December 31, 2020 2.88%
September 30, 2020 -2.63%
June 30, 2020 4.07%
March 31, 2020 3.09%
December 31, 2019 4.63%
September 30, 2019 1.47%
June 30, 2019 -3.18%
March 31, 2019 -0.42%
December 31, 2018 -3.62%
September 30, 2018 2.31%
June 30, 2018 -1.82%
March 31, 2018 -2.90%
December 31, 2017 -17.19%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Medpace Holdings, Inc. 17.16%
Champions Oncology, Inc. -2.80%
Personalis, Inc. -141.7%
Adaptive Biotechnologies Corp. -55.82%
10X Genomics, Inc. -11.87%